Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolus (EOLS) EBITDA (2018 - 2025)

Evolus (EOLS) has disclosed EBITDA for 8 consecutive years, with $111000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 101.58% year-over-year to $111000.0, compared with a TTM value of -$50.9 million through Dec 2025, changed 0.01%, and an annual FY2025 reading of -$50.9 million, changed 0.01% over the prior year.
  • EBITDA was $111000.0 for Q4 2025 at Evolus, up from -$15.3 million in the prior quarter.
  • Across five years, EBITDA topped out at $6.4 million in Q1 2021 and bottomed at -$23.5 million in Q2 2022.
  • Average EBITDA over 5 years is -$14.3 million, with a median of -$16.3 million recorded in 2021.
  • The sharpest move saw EBITDA soared 132.8% in 2021, then tumbled 375.02% in 2022.
  • Year by year, EBITDA stood at -$18.2 million in 2021, then rose by 27.75% to -$13.1 million in 2022, then rose by 11.28% to -$11.7 million in 2023, then surged by 39.86% to -$7.0 million in 2024, then soared by 101.58% to $111000.0 in 2025.
  • Business Quant data shows EBITDA for EOLS at $111000.0 in Q4 2025, -$15.3 million in Q3 2025, and -$16.9 million in Q2 2025.